ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Abilify Maintena 300 mg, Depot-Injektionssuspension in einer Fertigspritze - Fertigspritze(n)
65774002 Lundbeck (Schweiz) AG
Abilify Maintena 300 mg, Depot-Injektionssuspension in einer Fertigspritze15.03.2016
  15.03.2016
Aripiprazole (N05AX12) 
WHO-DDD 
01.05.Fertigspritze(n)
01.05. 
B  
No 
IP 
PR  
k.A.PR
  
7680657740028Synthetika
  
Composition
Praeparatio cryodesiccata: aripiprazolum 300 mg, aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, ad pulverem. Solvens: aqua ad iniectabile. Solutio reconstituta: aripiprazolum 300 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium max. 1.6 mg.
Packungsbestandteile
Praeparatio cryodesiccata:
Depot-Injektionssuspension in einer Fertigspritze
 
 
Active AgentDose
Aripiprazole300 mg
Aripiprazolum Monohydricum 
 
Inactive agents
Carmellose Sodium
Mannitol
Sodium Dihydrogenophosphate Monohydrate
Sodium Hydroxide
Source
Data was imported : 06.07.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home